Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naive patients with Crohn's disease with propensity score adjustment: two-year maintenance phase results from the prospective VEDO-IBD study

B. Bokemeyer, S. Plachta-Danielzik, P. Efken,W. Mohl, M. Hoffstadt,T. Krause,A. Schweitzer, E. Schnoy,R. Atreya,N. Teich, L. Trentmann,R. Ehehalt, S. Franzenburg,P. Hartmann, R. di Giuseppe,S. Schreiber

JOURNAL OF CROHNS & COLITIS(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要